10x Genomics, Inc. (TXG) Stock

10x Genomics, Inc. (TXG) is a Technology stock trading at $46.29 (as of 2026-07-24), with a market capitalization of $5.91B. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

10x Genomics, Inc. provides instruments, consumables, and software used to analyze biological systems, including single-cell and spatial genomics workflows. Its offerings include Chromium instruments and related chips and reagents, plus software and consumables for gene expression, immune profiling, ATAC, and combined ATAC plus gene expression, serving customers such as academic, government, and biopharmaceutical organizations.

Valuation — source: SEC EDGAR (first-party)
Price	$46.29
Market Cap	$5.91B
EV / EBITDA	3712.7
Price / Book	7.26
Price / Sales	9.42
FCF Yield	3.3%
DCF Value (model)	$10.29
DCF Upside vs Price	-77.8%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$642.82M
Net Margin	-6.8%
Revenue Growth (YoY)	5.2%
EPS Growth (YoY)	-77.0%
FCF Growth (YoY)	-2371.2%

Financial Health — source: SEC EDGAR
Altman Z-Score	13.48 (safe)

Valuation vs Sector & Industry
Sector P/E (Technology)	34.6
Industry P/E (Measuring & Control Equipment)	59.4

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	FMR LLC ($376.64M)
Institutional Holders Tracked	10

Company
Sector	Technology
Industry	Measuring & Control Equipment
CEO	Serge Saxonov
Employees	1,306
Country	US
IPO Date	2019-09-12

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

Data as of 2026-07-24.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.